Search

Your search keyword '"Ficial M"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Ficial M" Remove constraint Author: "Ficial M"
22 results on '"Ficial M"'

Search Results

1. Achieve clear cell renal cell carcinoma (CCRCC) cures through dual-targeted fine-tuned immune restoring (DFIR) CAR-T cell therapy

2. PD-L1 status and clinical outcomes to cabozantinib, sunitinib and everolimus in patients with metastatic clear-cell RCC treated on CABOSUN and METEOR clinical trials

3. Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

7. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects.

8. Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.

11. A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.

12. Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma.

13. Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma.

14. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.

15. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma.

16. PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN.

17. Liver Metastases From Renal Oncocytoma With Vascular Extension.

18. Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease.

19. Usefulness of breast cytology after lipofilling.

20. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.

21. Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors.

22. Keratin-14 expression in pneumocytes as a marker of lung regeneration/repair during diffuse alveolar damage.

Catalog

Books, media, physical & digital resources